Cargando…
SLC46A3 is a lysosomal proton-coupled steroid conjugate and bile acid transporter involved in transport of active catabolites of T-DM1
Antibody–drug conjugates (ADCs) represent a new class of cancer therapeutics that enable targeted delivery of cytotoxic drugs to cancer cells. Although clinical efficacy has been demonstrated for ADC therapies, resistance to these conjugates may occur. Recently, SLC46A3, a lysosomal membrane protein...
Autores principales: | Tomabechi, Ryuto, Kishimoto, Hisanao, Sato, Taeka, Saito, Naoki, Kiyomiya, Keisuke, Takada, Tappei, Higuchi, Kei, Shirasaka, Yoshiyuki, Inoue, Katsuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896951/ https://www.ncbi.nlm.nih.gov/pubmed/36741448 http://dx.doi.org/10.1093/pnasnexus/pgac063 |
Ejemplares similares
-
Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter
por: Higuchi, Kei, et al.
Publicado: (2022) -
Monocarboxylate Transporter 13 (MCT13/SLC16A13) Functions as a Novel Plasma Membrane Oligopeptide Transporter
por: Higuchi, Kei, et al.
Publicado: (2023) -
Functional identification of SLC43A3 as an equilibrative nucleobase transporter involved in purine salvage in mammals
por: Furukawa, Junji, et al.
Publicado: (2015) -
Corrigendum: Functional identification of SLC43A3 as an equilibrative nucleobase transporter involved in purine salvage in mammals
por: Furukawa, Junji, et al.
Publicado: (2016) -
Utilization of Sodium Nitroprusside as an Intestinal Permeation Enhancer for Lipophilic Drug Absorption Improvement in the Rat Proximal Intestine
por: Kishimoto, Hisanao, et al.
Publicado: (2021)